Steris (STE) Cash from Financing Activities (2018 - 2026)

Steris has reported Cash from Financing Activities for 8 years, with the latest figure at -$98.0 million in Q4 2025.

• For the quarter ending Q4 2025, Cash from Financing Activities rose 54.29% year-over-year to -$98.0 million; the trailing twelve-month figure through Dec 2025 stood at -$648.4 million (up 57.85% YoY), and the FY2025 full-year result was -$1.6 billion, down 1745.8% from the prior year.
• Cash from Financing Activities for Q4 2025 stood at -$98.0 million, up from -$159.2 million in the prior quarter.
• The five-year high for Cash from Financing Activities was $818.8 million in Q2 2021, with the low at -$998.9 million in Q2 2024.
• Average Cash from Financing Activities over 5 years is -$130.4 million, with a median of -$179.5 million recorded in 2024.
• Year-over-year, Cash from Financing Activities slumped 945.22% in 2021 and surged 1146.13% in 2023.
• Tracing STE's Cash from Financing Activities over 5 years: stood at -$189.3 million in 2021, then surged by 36.38% to -$120.4 million in 2022, then tumbled by 64.43% to -$198.0 million in 2023, then fell by 8.29% to -$214.4 million in 2024, then soared by 54.29% to -$98.0 million in 2025.
• The last three Cash from Financing Activities figures came in at -$98.0 million (Q4 2025), -$159.2 million (Q3 2025), and -$213.1 million (Q2 2025), per Business Quant data.

Peer Comparison